U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 futures muted as investors await big bank earnings; chip weakness weighs
- Oil retreats as Russian diesel supply prospects counter Gulf supply risks
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.40 | 52 Week High | $37.39 | |||
| Open | $28.40 | 52 Week Low | $28.25 | |||
| Day High | $28.40 | P/E | 17.21 | |||
| Day Low | $28.40 | EPS | $1.65 | |||
| Volume | 67,459 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.40 | 52 Week High | $37.39 | |||
| Open | $28.40 | 52 Week Low | $28.25 | |||
| Day High | $28.40 | P/E | 17.21 | |||
| Day Low | $28.40 | EPS | $1.65 | |||
| Volume | 67,459 | |||||
